Pharma-Bio Serv, Inc. (PBSV)
USD 0.46
(-9.8%)
USD 0.46
(-9.8%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -10.09 Million USD | 27.73% |
| 2022 | -13.97 Million USD | 17.06% |
| 2021 | -16.85 Million USD | -17.46% |
| 2020 | -14.34 Million USD | 6.92% |
| 2019 | -15.41 Million USD | 3.49% |
| 2018 | -15.97 Million USD | -36.75% |
| 2017 | -11.67 Million USD | 14.89% |
| 2016 | -13.72 Million USD | 7.4% |
| 2015 | -14.81 Million USD | 1.15% |
| 2014 | -14.99 Million USD | -25.32% |
| 2013 | -11.96 Million USD | -86.48% |
| 2012 | -6.41 Million USD | -52.97% |
| 2011 | -4.19 Million USD | -86.78% |
| 2010 | -2.24 Million USD | -15.38% |
| 2009 | -1.94 Million USD | 36.05% |
| 2008 | -3.04 Million USD | 35.95% |
| 2007 | -4.75 Million USD | -112.43% |
| 2006 | -2.23 Million USD | -4372.32% |
| 2005 | -50 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -6.1 Million USD | 39.56% |
| 2024 Q3 | -6.28 Million USD | -94.18% |
| 2024 Q2 | -3.23 Million USD | 46.96% |
| 2023 FY | -10.09 Million USD | 27.73% |
| 2023 Q2 | -7.67 Million USD | -13.38% |
| 2023 Q1 | -6.77 Million USD | 51.54% |
| 2023 Q3 | -2.48 Million USD | 67.61% |
| 2023 Q4 | -10.09 Million USD | -306.12% |
| 2022 Q2 | -12.61 Million USD | 14.6% |
| 2022 Q3 | -13.71 Million USD | -8.78% |
| 2022 FY | -13.97 Million USD | 17.06% |
| 2022 Q4 | -13.97 Million USD | -1.88% |
| 2022 Q1 | -14.76 Million USD | 12.38% |
| 2021 Q3 | -15.8 Million USD | -17.87% |
| 2021 FY | -16.85 Million USD | -17.46% |
| 2021 Q2 | -13.4 Million USD | 17.41% |
| 2021 Q4 | -16.85 Million USD | -6.64% |
| 2021 Q1 | -16.23 Million USD | -13.14% |
| 2020 Q4 | -14.34 Million USD | -2.55% |
| 2020 FY | -14.34 Million USD | 6.92% |
| 2020 Q1 | -14.29 Million USD | 7.24% |
| 2020 Q2 | -12.72 Million USD | 11.0% |
| 2020 Q3 | -13.98 Million USD | -9.94% |
| 2019 FY | -15.41 Million USD | 3.49% |
| 2019 Q1 | -15.74 Million USD | 1.43% |
| 2019 Q2 | -15.34 Million USD | 2.49% |
| 2019 Q3 | -14.71 Million USD | 4.14% |
| 2019 Q4 | -15.41 Million USD | -4.74% |
| 2018 Q4 | -15.97 Million USD | -5.59% |
| 2018 Q3 | -15.12 Million USD | -17.07% |
| 2018 Q2 | -12.91 Million USD | 1.42% |
| 2018 Q1 | -13.1 Million USD | -12.23% |
| 2018 FY | -15.97 Million USD | -36.75% |
| 2017 FY | -11.67 Million USD | 14.89% |
| 2017 Q3 | -12.12 Million USD | 4.28% |
| 2017 Q2 | -12.66 Million USD | 7.06% |
| 2017 Q1 | -13.62 Million USD | 0.71% |
| 2017 Q4 | -11.67 Million USD | 3.65% |
| 2016 Q4 | -13.72 Million USD | 1.64% |
| 2016 Q2 | -14.36 Million USD | 0.57% |
| 2016 Q1 | -14.44 Million USD | 2.51% |
| 2016 FY | -13.72 Million USD | 7.4% |
| 2016 Q3 | -13.95 Million USD | 2.88% |
| 2015 Q3 | -13.92 Million USD | 2.74% |
| 2015 FY | -14.81 Million USD | 1.15% |
| 2015 Q1 | -14.95 Million USD | 0.24% |
| 2015 Q2 | -14.31 Million USD | 4.25% |
| 2015 Q4 | -14.81 Million USD | -6.4% |
| 2014 FY | -14.99 Million USD | -25.32% |
| 2014 Q2 | -12.67 Million USD | 7.51% |
| 2014 Q3 | -13.65 Million USD | -7.72% |
| 2014 Q4 | -14.99 Million USD | -9.76% |
| 2014 Q1 | -13.7 Million USD | -14.61% |
| 2013 Q4 | -11.96 Million USD | -32.83% |
| 2013 Q3 | -9 Million USD | -7.35% |
| 2013 Q2 | -8.38 Million USD | -21.61% |
| 2013 Q1 | -6.89 Million USD | -7.54% |
| 2013 FY | -11.96 Million USD | -86.48% |
| 2012 Q1 | -4.05 Million USD | 3.35% |
| 2012 Q2 | -3.86 Million USD | 4.58% |
| 2012 Q3 | -4.92 Million USD | -27.4% |
| 2012 Q4 | -6.41 Million USD | -30.2% |
| 2012 FY | -6.41 Million USD | -52.97% |
| 2011 Q1 | -2.33 Million USD | -4.2% |
| 2011 FY | -4.19 Million USD | -86.78% |
| 2011 Q4 | -4.19 Million USD | -21.29% |
| 2011 Q3 | -3.45 Million USD | -43.2% |
| 2011 Q2 | -2.41 Million USD | -3.2% |
| 2010 FY | -2.24 Million USD | -15.38% |
| 2010 Q2 | -2.46 Million USD | -12.4% |
| 2010 Q3 | -1.85 Million USD | 24.72% |
| 2010 Q1 | -2.18 Million USD | -12.54% |
| 2010 Q4 | -2.24 Million USD | -21.18% |
| 2009 Q2 | -1.85 Million USD | -23.42% |
| 2009 FY | -1.94 Million USD | 36.05% |
| 2009 Q4 | -1.94 Million USD | 4.42% |
| 2009 Q3 | -2.03 Million USD | -9.47% |
| 2009 Q1 | -1.5 Million USD | 50.48% |
| 2008 Q1 | -5.3 Million USD | -11.66% |
| 2008 Q3 | -2.15 Million USD | 6.64% |
| 2008 Q2 | -2.31 Million USD | 56.44% |
| 2008 FY | -3.04 Million USD | 35.95% |
| 2008 Q4 | -3.04 Million USD | -41.07% |
| 2007 Q1 | -2.38 Million USD | -6.59% |
| 2007 Q2 | -3.26 Million USD | -37.15% |
| 2007 Q3 | -3.13 Million USD | 4.03% |
| 2007 Q4 | -4.75 Million USD | -51.41% |
| 2007 FY | -4.75 Million USD | -112.43% |
| 2006 Q4 | -2.23 Million USD | -64.87% |
| 2006 Q2 | -2.21 Million USD | 27.39% |
| 2006 FY | -2.23 Million USD | -4372.32% |
| 2006 Q3 | -1.35 Million USD | 38.7% |
| 2006 Q1 | -3.04 Million USD | 0.0% |
| 2005 FY | -50 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Achiko AG | 2.48 Million USD | 505.783% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 3.95 Million USD | 355.585% |
| Cannabis Sativa, Inc. | 206.45 Thousand USD | 4991.816% |
| CompuMed, Inc. | -686.23 Thousand USD | -1371.741% |
| CompuGroup Medical SE & Co. KGaA | 775.35 Million USD | 101.303% |
| Cogstate Limited | -29.45 Million USD | 65.708% |
| CareView Communications, Inc. | 19.88 Million USD | 150.799% |
| Craneware plc | 783 Thousand USD | 1389.852% |
| Caduceus Software Systems Corp. | 2.38 Million USD | 522.919% |
| Certive Solutions Inc. | 5.68 Million USD | 277.706% |
| Drug Free Solution, Inc. | -12.5 Thousand USD | -80683.435% |
| DATATRAK International, Inc. | 103.82 Thousand USD | 9827.376% |
| Strainsforpains, Inc. | 1.93 Million USD | 622.899% |
| Healixa Inc. | 6.5 Million USD | 255.278% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | -668.66 Thousand USD | -1410.395% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | 459.64 Thousand USD | 2297.249% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | 5062.82 USD | 199584.576% |
| IQ-AI Limited | -176.63 Thousand USD | -5617.91% |
| Cannabiz Mobile, Inc. | 494.04 Thousand USD | 2144.26% |
| Mednow Inc. | 2.11 Million USD | 576.53% |
| Galileo Life Sciences, Inc. | 17.02 Thousand USD | 59425.335% |
| MediXall Group, Inc. | 2.81 Million USD | 458.454% |
| Mitesco, Inc. | 1.76 Million USD | 672.579% |
| MobileSmith, Inc. | 4.85 Million USD | 307.95% |
| NantHealth, Inc. | 265.64 Million USD | 103.802% |
| Net Medical Xpress Solutions, Inc. | 661 Thousand USD | 1627.919% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | 8.48 Million USD | 219.037% |
| Patient Access Solutions, Inc. | 910.34 Thousand USD | 1209.417% |
| PPJ Healthcare Enterprises, Inc. | 2.54 Million USD | 497.004% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | 1277.427% |
| Renalytix Plc | 3.85 Million USD | 361.986% |
| Revium Recovery Inc. | -529 Thousand USD | -1809.177% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | -414.83 Thousand USD | -2334.611% |
| Vaso Corporation | -9.28 Million USD | -8.808% |
| Vynleads, Inc. | 513.29 Thousand USD | 2067.595% |